期刊文献+

人类P100蛋白表达抑制稳定株的建立及其对HeLa细胞周期的影响 被引量:1

Effects of the Stable Down-Expression of Human P100 Protein on Cell Cycle in HeLa Cell Line
原文传递
导出
摘要 目的构建针对人类P100(hP100)基因的小干扰RNA(small interfering RNA,siRNA)质粒,转染后筛选P100表达抑制的稳定细胞株并鉴定其表达情况;同时检测其对细胞周期的影响。方法设计针对hP100基因的siRNA序列,构建pGenesil-shRNA-hP100质粒(smallhairpinRNA,shRNA,小发夹RNA),经测序鉴定后转染入宫颈癌细胞HeLa;经G418筛选出稳定株;Western印迹检测稳定株之抑制率。流式细胞术检测hP100蛋白表达抑制对细胞周期的影响。结果成功构建了针对hP100的siRNA质粒,并用之筛选出hP100蛋白表达抑制的稳定株,瞬时转染及稳定株hP100表达明显降低。流式细胞术显示抑制hP100蛋白表达使G1期细胞比例增加,S期和G2/M期细胞比例降低。结论RNAi(RNA interference,RNA干扰)可持续稳定地抑制人类P100蛋白的表达,人类P100蛋白表达抑制对细胞周期有调节作用。 Objective To suppress the expression of human P100 gene by RNA interference, screen the stable transfectant and observe its influence on cell cycle. Methods The stable screening inhibition of RNAi was used to stably suppress the expression of P100 protein. After small hairpin RNA (shRNA) targeting human P100 gene was designed, recombinant vector pGenesil-shRNA- hP100 was constructed and transfected into Hela cells, which were selected by using C,418 to establish stable transfectant, hP100 expression was detected by Western blotting and the suppression efficiency was calculated in transiently transfected cells and stable transfectant separately. The cell cycle distribution was detected by flow cytometry (FCM) . Results pGenesil-shRNA-hP100 plasmid was constructed successfully, and the hP100 expression in both transient transfection and stable transfectant were obviously suppressed as compared with that in negative control group. Compared with the control, cell cycle of the stable transfectant was prolonged in G1 phase. Conclusion RNAi may continually and stably suppress hP100 protein expression and the inhibited expression of P100 protein could regulate cell cycle in HeLa cell line.
出处 《医学分子生物学杂志》 CAS CSCD 2008年第3期240-243,共4页 Journal of Medical Molecular Biology
基金 国家高技术研究发展计划(863计划)(No.2007AA02Z115) 教育部新世纪人才支持计划 国家自然科学基金(No.30670441 30300070) 天津市科委应用基础研究重点项目(No.07JCZDJC07300) 天津市科委国际合作项目(No.05YFGHHZ01300)~~
关键词 人类P100蛋白 RNA干扰 稳定株 细胞周期 human P100 protein RNA interference stable transfectant cell cycle
  • 相关文献

参考文献13

  • 1[1]TONG X,DRAPKIN R,YALAMANCHILI R,et al.Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE[J].Mol Cell Biol,l995,l5(9):4735-4744.
  • 2杨洁,姚智,郁春艳,Olli Silvennoinen.人p100蛋白:可增强STAT6基因转录活性的新因子[J].中国免疫学杂志,2004,20(11):739-742. 被引量:6
  • 3[3]YANG J,VLINEVA T,HONG J,et al.Transcriptional co-activator protein P100 interacts with snRNP proteins and facilitates the assembly of the spliceosome[J].Nucleic Acids Res,2007,35(13):1-10.
  • 4[4]ELBASHIR S M,HARBORTH J,LENDECKEL W,et al.Dupl-exes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411(6836):494-498.
  • 5[5]VLINEVA T,YANG J,PALOVUORI R,et al.The transcriptional co-activator protein P100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6[J].J Biol Chem,2005,280(15):14989-14996.
  • 6[6]YANG J,AITTOMAKI S,PESU M,et al.Identification of P100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II[J].EMBO J,2002,21(18):4950-4958.
  • 7[7]LEVERSON J D,KOSKINEN P J,ORRICO F C,et al.Pim-1 kinase and P100 cooperate to enhance c-Myb activity[J].Mol Cell,1998,2(4):417-425.
  • 8[8]TIJMS M A,SNIJDER E J.Equine arteritis virus non-structural protein 1,an essential factor for viral subgenomic mRNA synthesis,interacts with the cellular transcription co-factor P100[J].J Gen Virol,2003,84:2317-2322.
  • 9[9]O'CONNELL M A,KEEGAN L P.Drosha versus ADAR:wrangling over pri-miRNA[J].Nat Struct Mol Biol,2006,13(1):3-4.
  • 10[10]YANG W,CHENDRIMADA R P,WANG Q,et al.Modulation of microRNA processing and expression through RNA editing by ADAR deaminases[J].Nat Struct Mol Biol,2006,13:13-21.

二级参考文献7

  • 1[1]Quelle F W, Shimoda K,Thierfelder W et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis [J].Mol Cell Biol,1995; 15: 3336-3343.
  • 2[2]Muller M, Briscoe J, Laxton C et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction [J]. Nature, 1993;366:114-116.
  • 3[3]Wei D, Le X, Zheng L et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis [J]. Oncogene,2003;22(3) :319-329.
  • 4[4]Duetsch G, Illig T, Loesgen S et al. STAT6 as an asthma candidate gene:polymorphism-screening,association and haplotype analysis in a Caucasian sib-pair study [J]. Hum Mol Genet, 2002; 11 (6): 613-621.
  • 5[5]Blease K, Schuh J M, Jakubzick C et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma [J]. Am J Pathol,2002; 160(2) :481-490.
  • 6[6]Shuai K. Modulation of STAT signaling by STAT-interacting proteins [J].Oncogene,2000; 19:2638-2644.
  • 7[7]Tong X, Drapkin R,Yalamanchili R et al. (1995) The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE [J].Mol Cell Biol,1995;15:4735-4744.

共引文献5

同被引文献9

  • 1Guo D S, Holmlund C, Henriksson R, et al. The LR- IG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Aseidiacea [J]. Genomics,2004,84(2) : 157-165.
  • 2Holmlund C, Nilsson J, Guo D S, et al. Characterization and tissue-specific expression of human LRIG2 [J]. Gene, 2004, 332(1) :35-43.
  • 3Hedman H,Nilsson J,Guo D S,et al. Is LRIG1 atumor suppressor gene at chromosome 3p14.3 ?[J]. Acta Oncologica, 2002,41(3) :352- 354.
  • 4Milhavet O,Gary D S,Matt Son M P. RNA interference in biology and medicine[J]. Pharmacol Rev, 2003,55 (4) : 629-648.
  • 5Vorburger S A, Hunt K K. Adenoviral genetherapy [J]. Oncologist, 2002,7 ( 1 ) :46-59.
  • 6Guo D S, Nilsson J, Haapasalo H, et al. Perinuclear leucinerich repeats and immunoglobulin like domain proteins (LRIG1 -3)as prognostic indicators in astrocytic tumors [J]. Acta Neuropathol,2006,111 (3) :238-246.
  • 7Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference[J]. Nat Biotechnol, 2004,22 (3) : 326- 330.
  • 8Yu J Y,Deruiter S L,Turner D L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J]. Proc Natl Acad Sci USA, 2002,99 ( 9 ) : 6047- 6052.
  • 9张士龙,曾甫清,彭世波,董继华,廖贵益,汪良.shRNA沉默基因DNMT1的表达对膀胱癌T24细胞增殖与凋亡的影响[J].华中科技大学学报(医学版),2009,38(2):165-168. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部